EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and internal validation of an interpretable machine learning-based risk stratification model for sarcopenic obesity in patients with type 2 diabetes mellitus

Entwicklung und interne Validierung eines interpretierbaren Machine-Learning-Modells zur Risikostratifizierung für sarkopenische Adipositas bei Patient:innen mit Typ-2-Diabetes mellitus

Ting Shi, Xiaohong Liu, Meiling Fu, Yuxuan Lu, Qi Li, Jie Zou, Yinqin Zhong, Yun Chen

Frontiers in Medicine · 02.11.2026 · 13

DOI: 10.3389/fmed.2026.1893262 ↗

Auf einen Blick

Bei 378 Patient:innen mit Typ-2-Diabetes mellitus wurde ein Modell zur Risikostratifizierung für sarkopenische Adipositas entwickelt und intern validiert. LightGBM zeigte die numerisch beste AUC.

Fragestellung

Welche Faktoren sind mit sarkopenischer Adipositas bei Patient:innen mit Typ-2-Diabetes assoziiert, und lässt sich dafür ein internes Risikomodell entwickeln?

Methode

Einzentrumige Querschnittsstudie; 378 Patient:innen mit T2DM; 7:3-Aufteilung in Trainings- und Validierungsset; Modelle: logistische Regression, Random Forest, SVM, LightGBM, XGBoost; SHAP und Bootstrap.

Ergebnisse

Prävalenz von SO: 36,2 %. Wichtige Faktoren: Alter, ADL, Taillenumfang, HDL und 25(OH)D. LightGBM: AUC 0,821 (95 %-KI 0,744–0,897), AUPRC 0,712; AUC-Unterschiede nicht signifikant.

Einschränkungen

Bootstrap-Validierung zeigte bei LightGBM eine gewisse Optimismusverzerrung und Unterkalibrierung.

Schlussfolgerung der Autor:innen

Die mit Machine Learning entwickelten SO-Risikostratifikationsmodelle zeigten gute Leistung und potenzielle klinische Nützlichkeit; LightGBM erzielte die höchste numerische Leistung.

Kernaussagen

  • SO-Prävalenz bei T2DM: 36,2 %
  • LightGBM: AUC 0,821 (95 %-KI 0,744–0,897)
  • Alter war das wichtigste Prädiktionsmerkmal

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 02.11.2026. Verfasst von Ting Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, China. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Innovation Program.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To analyze the factors associated with sarcopenic obesity (SO) in patients with type 2 diabetes (T2DM), and to develop and internally validate an SO risk stratification model based on interpretable machine learning, thereby providing guidance for the clinical screening of high-risk patients and the implementation of personalized risk assessment.

Methods

A single-center cross-sectional study design was adopted, enrolling 378 patients with T2DM, who were divided into an SO group and a non-SO group based on SO diagnostic results. Demographic characteristics, disease-related data, anthropometric measurements, and laboratory test results were collected. The cohort was randomly divided into a training set ( n = 265) and a validation set ( n = 113) in a 7:3 ratio. Univariate analysis, LASSO regression, and multivariate logistic regression were used to identify factors associated with SO, and based on these results, five risk-stratification models were constructed: logistic regression, random forest, SVM, LightGBM, and XGBoost. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), area under the precision-recall curve (AUPRC), accuracy, sensitivity, recall, precision, F1 score, and Brier score. Model calibration performance and clinical applicability were assessed using calibration curves, calibration slope, calibration intercept, calibration-in-the-large (CITL), and decision curve analysis (DCA). Supplementary internal validation of the LightGBM model was performed using 1,000 bootstrap resamples, and interpretability analysis was conducted using the SHAP method.

Results

In this study, the detection rate of SO in patients with T2DM was 36.2%, age, ADL, waist circumference, HDL, and 25(OH)D were the primary factors influencing SO. The AUC values of the five models on the validation set ranged from 0.806 to 0.821. Among them, LightGBM achieved the numerically highest AUC in this sample, at 0.821 (95% CI: 0.744–0.897), with an AUPRC of 0.712; however, the DeLong test indicated that the differences in AUC among the models were not statistically significant (all P > 0.05). Overall, the models demonstrated good calibration performance and potential clinical net benefit; however, bootstrap internal validation indicated that LightGBM still exhibited a certain degree of optimism bias and under-calibration. SHAP analysis revealed that age, ADL, waist circumference, HDL, and 25(OH)D contributed significantly to model predictions, with age being the most important predictive feature.

Conclusion

The SO risk stratification models developed using machine learning methods demonstrated good performance and potential clinical utility, with LightGBM achieving the highest numerical performance. SHAP-based interpretability analysis enhanced model transparency and clinical credibility, providing a reference for assisted screening, risk stratification, and individualized assessment of SO in patients with T2DM.

Schlagwörter

Stichwörter der Autor:innen

internal validationmachine learningrisk stratification modelsarcopenic obesitytype 2 diabetes mellitus

Autor:innen und Institutionen

  • Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, China.
  • The Sixth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen, China.

Förderung

  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Shi, T., Liu, X., Fu, M., Lu, Y., Li, Q., Zou, J., Zhong, Y., & Chen, Y. (2026). Development and internal validation of an interpretable machine learning-based risk stratification model for sarcopenic obesity in patients with type 2 diabetes mellitus. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1893262

Vancouver

Shi T, Liu X, Fu M, Lu Y, Li Q, Zou J, et al. Development and internal validation of an interpretable machine learning-based risk stratification model for sarcopenic obesity in patients with type 2 diabetes mellitus. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1893262

BibTeX
@article{Shi2026,
  author = {Shi, Ting and Liu, Xiaohong and Fu, Meiling and Lu, Yuxuan and Li, Qi and Zou, Jie and Zhong, Yinqin and Chen, Yun},
  title = {Development and internal validation of an interpretable machine learning-based risk stratification model for sarcopenic obesity in patients with type 2 diabetes mellitus},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1893262}
}
Kostenlos starten →